Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 3 | 103 | 3 | 171 | 78 |
| Gross Profit | 3 | 103 | 3 | 171 | 78 |
| Operating Expenses | 3,238 | 2,994 | 2,729 | 2,754 | 2,461 |
| Operating Income | -3,236 | -2,892 | -2,727 | -2,583 | -2,383 |
| Interest Expense | 439 | 48 | 1 | 0 | 1 |
| Other Income | -2,577 | -650 | 14 | 5 | 8 |
| Pre-tax Income | -6,252 | -3,590 | -2,714 | -2,579 | -2,376 |
| Net Income Continuous | -6,252 | -3,590 | -2,714 | -2,579 | -2,376 |
| Net Income | $-6,252 | $-3,590 | $-2,714 | $-2,579 | $-2,376 |
| EPS Basic Total Ops | -0.09 | -0.05 | -0.04 | -0.04 | -0.04 |
| EPS Basic Continuous Ops | -0.09 | -0.05 | -0.04 | -0.04 | -0.04 |
| EPS Diluted Total Ops | -0.09 | -0.05 | -0.04 | -0.04 | -0.04 |
| EPS Diluted Continuous Ops | -0.09 | -0.05 | -0.04 | -0.04 | -0.04 |
| EBITDA(a) | $-2,969 | $-2,819 | $-2,680 | $-2,495 | $-2,342 |